MSH's MISSION: Saving lives and improving the health of the world's poorest and most vulnerable people by closing the gap between knowledge and action in public health.About MTaPS: Funded by the US Agency for International Development (USAID) and implemented by a consortium led by Management Sciences for Health (MSH), Medicine Technologies and Pharmaceutical Services (MTaPS).The five-year program builds upon the work of its predecessor program, the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS). with the aim to improve access to quality pharmaceutical products and effective pharmaceutical services through systems strengthening for lasting, positive health outcomes.The MTaPS Goal: aims to help low- and middle-income countries strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medicines and pharmaceutical services.The MTaPS Objective: MTaPS approach to strengthening of pharmaceutical systems focuses on improvements in seven technical areas to ensure robust and resilient outcomes:· Improve pharmaceutical sector governance· Strengthen the national regulatory system· Increase institutional and human resource capacity· Increase the availability and use of pharmaceutical information for decision-making· Improve pharmaceutical sector financing· Strengthen supply chain management· Enhance pharmaceutical services, including building pharmacovigilance systems and improving pharmacy practicesSustainable access to safe, effective and quality-assured medicines and their appropriate use by all populations are key to eliminating epidemics and preventing avoidable deaths. MTaPS works with countries in the following health areas to drive better health outcomes in a sustained way:
MSH's MISSION: Saving lives and improving the health of the world's poorest and most vulnerable people by closing the gap between knowledge and action in public health.About MTaPS: Funded by the US Agency for International Development (USAID) and implemented by a consortium led by Management Sciences for Health (MSH), Medicine Technologies and Pharmaceutical Services (MTaPS).The five-year program builds upon the work of its predecessor program, the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS). with the aim to improve access to quality pharmaceutical products and effective pharmaceutical services through systems strengthening for lasting, positive health outcomes.The MTaPS Goal: aims to help low- and middle-income countries strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medicines and pharmaceutical services.The MTaPS Objective: MTaPS approach to strengthening of pharmaceutical systems focuses on improvements in seven technical areas to ensure robust and resilient outcomes:· Improve pharmaceutical sector governance· Strengthen the national regulatory system· Increase institutional and human resource capacity· Increase the availability and use of pharmaceutical information for decision-making· Improve pharmaceutical sector financing· Strengthen supply chain management· Enhance pharmaceutical services, including building pharmacovigilance systems and improving pharmacy practicesSustainable access to safe, effective and quality-assured medicines and their appropriate use by all populations are key to eliminating epidemics and preventing avoidable deaths. MTaPS works with countries in the following health areas to drive better health outcomes in a sustained way:
MSH's MISSION: Saving lives and improving the health of the world's poorest and most vulnerable people by closing the gap between knowledge and action in public health.About MTaPS: Funded by the US Agency for International Development (USAID) and implemented by a consortium led by Management Sciences for Health (MSH), Medicine Technologies and Pharmaceutical Services (MTaPS).The five-year program builds upon the work of its predecessor program, the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS). with the aim to improve access to quality pharmaceutical products and effective pharmaceutical services through systems strengthening for lasting, positive health outcomes.The MTaPS Goal: aims to help low- and middle-income countries strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medicines and pharmaceutical services.The MTaPS Objective: MTaPS approach to strengthening of pharmaceutical systems focuses on improvements in seven technical areas to ensure robust and resilient outcomes:· Improve pharmaceutical sector governance· Strengthen the national regulatory system· Increase institutional and human resource capacity· Increase the availability and use of pharmaceutical information for decision-making· Improve pharmaceutical sector financing· Strengthen supply chain management· Enhance pharmaceutical services, including building pharmacovigilance systems and improving pharmacy practicesSustainable access to safe, effective and quality-assured medicines and their appropriate use by all populations are key to eliminating epidemics and preventing avoidable deaths. MTaPS works with countries in the following health areas to drive better health outcomes in a sustained way: